Related Experiment Video

Updated: Jul 10, 2026

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Altered levels of Smad2 and Smad4 are associated with human prostate carcinogenesis

M C Perttu1, P M Martikainen, H S A Huhtala

  • 1Department of Anatomy, Medical School, University of Tampere, Tampere, Finland. mika.perttu@uta.fi

Prostate Cancer and Prostatic Diseases
|March 22, 2006
PubMed

Insights

Prostate cancer (PC) shows altered transforming growth factor beta (TGF-beta) signaling. This study reveals reversible changes in the Smad cascade, a key part of TGF-beta signaling, during prostate carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The transforming growth factor beta (TGF-beta) pathway is crucial in cellular processes.
  • Alterations in the TGF-beta pathway's ligand and receptor system are observed in prostate cancer (PC).
  • The activity of the intracellular Smad cascade within TGF-beta signaling during prostate carcinogenesis remains largely unknown.

Purpose of the Study:

  • To investigate changes in the Smad cascade of the TGF-beta signaling pathway during prostate carcinogenesis.
  • To analyze the levels of phosphorylated Smad2 (p-Smad2), nuclear Smad4, and Smad7 in normal, hyperplastic, and malignant prostate tissues.

Main Methods:

  • Immunohistochemistry was employed to detect p-Smad2, nuclear Smad4, and Smad7.
  • Analysis was performed on 49 prostate cancer tissue cores, 10 benign prostate hypertrophy samples, and 3 normal prostate samples.

Main Results:

  • Significantly decreased levels of nuclear p-Smad2 (P<0.001) and nuclear Smad4 (P=0.023) were observed in prostate cancer tissues.
  • Cytoplasmic Smad7 levels exhibited notable variations.
  • p-Smad2 and Smad4 levels decreased in primary Gleason grades 3 and 4 but increased markedly in grade 5.

Conclusions:

  • This study provides the first evidence of alterations and reversible attenuation in the Smad system of the TGF-beta pathway during prostate carcinogenesis.
  • These findings highlight the dynamic role of TGF-beta signaling in prostate cancer development.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - &#946; Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...